-
RG7112 is a potent, selective, first clinical and orally active MDM2-p53 inhibitor, with a KD of 11 nM for binding to MDM2.
Categories
Others
Archives
- August 2019 (1)
Thanks, your subscription has been confirmed. You will hear from us soon.
Submission failed, please try again later.
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.